MedPath
TGA Approval

CIPLA APREMILAST apremilast 30 mg tablet blister pack (460187)

460187

CIPLA APREMILAST apremilast 30 mg tablet blister pack

Cipla Australia Pty Ltd

May 9, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

apremilast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CIPLA APREMILAST apremilast 30 mg tablet blister pack (460187) - TGA 批准文号 | MedPath